症状与病史能否预测氢和甲烷呼气试验结果?
一项在英国单中心开展的731例乳果糖氢和甲烷呼气试验(HMBT)患者调查显示,腹痛、嗳气、反流等肠易激综合征样症状及皮肤状况与小肠细菌过度生长(SIBO)相关,便秘和脂肪泻与肠道产甲烷菌过度生长(IMO)相关,支持按现行指南使用HMBT。
要点
- 腹痛、嗳气、反流及餐后腹痛/不适与SIBO相关。
- 便秘和漂浮的脂肪/油腻粪便与IMO相关。
- 至少一种皮肤状况与SIBO阳性可能性更高相关。
核心结论
- 肠易激综合征样症状、难治性胃食管反流症状和皮肤状况与HMBT结果相关。
- 这些发现支持按照现行临床指南使用HMBT。
研究设计与样本
- 在英国单中心对731例完成乳果糖HMBT的患者进行大型问卷调查。
- 32项调查问卷包括症状和病史问题,采用Fisher精确检验和回归模型分析。
主要发现
- 腹痛(P=0.022)、过度嗳气(P=0.041)和反流(P=0.034)与SIBO相关。
- 每日腹痛伴腹泻(P=0.035)及餐后立即腹痛或不适(OR 2.20,95%CI 1.29-3.79)与SIBO相关。
- 至少一种皮肤状况的患者SIBO阳性可能性更高,湿疹(P=0.051)和酒渣鼻(P=0.067)呈临界显著性趋势。
- IMO与便秘(P<0.001)和漂浮的脂肪/油腻粪便(P<0.001)相关。
关键数值与推荐
- SIBO定义为90分钟内呼气氢较基线升高≥20 ppm。
- IMO定义为任何呼气样本中甲烷≥10 ppm。
临床怎么用
- 对于有肠易激综合征样症状、难治性反流症状或皮肤状况的患者,可考虑行HMBT评估SIBO。
- 便秘或漂浮脂肪泻患者应怀疑IMO。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hydrogen and methane breath testing (HMBT) is used to diagnose small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO). There are limited data on whether symptoms and medical history can predict outcomes on lactulose HMBT. METHODS: A large survey-based study was conducted in 731 patients who completed lactulose HMBT at a single tertiary center in the United Kingdom. The 32-item survey included questions relating to symptoms and medical history. Survey items were statistically interrogated to determine associations with SIBO, IMO, or breath gas production using Fisher exact tests and regression models. SIBO was determined by a rise of ≥20 ppm in breath hydrogen from baseline within 90 minutes and IMO by the presence of ≥10 ppm methane in any breath sample. RESULTS: Abdominal pain ( P = 0.022), excessive belching ( P = 0.041), and regurgitation ( P = 0.034) were associated with SIBO, as well as daily abdominal pain with diarrhea ( P = 0.035), and abdominal pain or discomfort immediately after eating (odds ratio 2.20, 95% CI 1.29-3.79). Patients reporting at least 1 skin condition were more likely to test positive for SIBO, with a trend toward significance for eczema ( P = 0.051) and rosacea ( P = 0.067). IMO was associated with constipation ( P < 0.001) and with fatty/greasy stools that tend to float ( P < 0.001). DISCUSSION: This large questionnaire study demonstrated that irritable bowel syndrome-like symptoms, refractory gastroesophageal reflux symptoms, and skin conditions are associated with outcomes on HMBT. These findings support the use of HMBT in accordance with current clinical guidelines.
引用
- Haworth JJ, Treadway S, Bloor S, et al. Can Symptoms and Medical History Predict Outcomes for Hydrogen and Methane Breath Testing? Am J Gastroenterol. 2025. PMID: 40788605. doi:10.14309/ajg.0000000000003697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。